Pediatric Infectious Disease: Part II, An Issue of Infectious Disease Clinics of North America

Mary Anne Jackson

Description

This issue of Infectious Disease Clinics of North America, Guest Edited by Mary Anne Jackson, MD and Angela Myers, MD, is Part II of a 2-part issue devoted to Pediatric Infectious Diseases. Drs. Jackson and Myers have assembled a group of expert authors to review the following topics: Measles 50 Years After Initiation of MMR Vaccine; Pertussis in the Era of New Strains; Promoting Vaccine Confidence; The Changing Epidemiology of Meningococcal Infection; Prevention of Influenza in Children; Rabies - Rare Human Infection, Common Questions; The Expanded Impact of Human Papillomavirus Vaccine; The Challenge of Global Poliomyelitis Eradication; The Eradication of Pediatric Rotavirus Infection; Approach to Immunization for the Traveling Child; and Status of Pneumococcal Infection in the US in the conjugate vaccine era.

Sujets

• Médecine
• Médecine Générale
• Infectious Diseases
• Medical

Informations

• Publié par: Elsevier
• Date de parution: 19 janvier 2016
• Nombre de lectures: 0
• EAN13: 9780323402538
• Langue: English
• Poids de l'ouvrage: 2 Mo

Extrait

Pediatric Infectious Disease: Part II
Infectious Disease Clinics of North America
Editors
Mary Anne Jackson, MD, FAAP, FPIDS
Infectious Diseases, Children s Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA
Angela L. Myers, MD, MPH, FAAP, FPIDS
Children s Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA
Consulting Editors
Helen W. Boucher

Clinics Review Articles

www.id.theclinics.com

December 2015 Volume 29 Number 4
Table of Contents
Cover image
Title page
Copyright
Contributors
Consulting Editor
Editors
Authors
Forthcoming Issues
Forthcoming Issues
Recent Issues
Preface. Pediatric Infectious Diseases, Part 2
Prevention of Influenza in Children
Key points
Introduction
Incidence and mortality rates
Patient history
Physical examination
Additional testing and imaging
Treatment and chemoprophylaxis
Clinical outcomes and complications
Prevention
Summary
References
Rotavirus Infection: A Disease of the Past?
Key points
Rotavirus disease burden
Clinical aspects of rotavirus disease
Epidemiology of rotavirus disease
Prospects of Eradication of Rotavirus Disease
Available rotavirus vaccines
Challenges and opportunities
References
Rabies: Rare Human Infection - Common Questions
Key points
Natural history
Diagnosis
Prognosis
Management
Complications
Evidence
Controversies
References
The Challenge of Global Poliomyelitis Eradication
Key points
Introduction
Polio as a candidate for eradication
Clinical aspects of polio
Epidemiology of polio
Progress toward global eradication of polio
Eradication strategies
Available vaccines
Using oral and inactivated poliovirus vaccines together
Endgame strategy and timeline
Challenges and opportunities
Posteradication risks and mitigation
Research needs
Role of North American physicians
References
The Changing Epidemiology of Meningococcal Disease
Key points
Introduction
The disease as candidate for eradication
Clinical aspects
Epidemiology
Available vaccines
Impact of vaccination on disease control
Challenges and opportunities
Research needs
References
Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine
Key points
Epidemiology
Pneumococcal disease in children with comorbid conditions
Laboratory diagnosis
Treatment
Prevention
Summary
References
Pertussis in the Era of New Strains of Bordetella pertussis
Key points
Etiology, transmission, and virulence
Epidemiology
Clinical features
Diagnosis
Treatment
Prevention strategies
References
The Expanded Impact of Human Papillomavirus Vaccine
Key points
Introduction
Etiology
Incidence and prevalence
Transmission
Clinical presentation
Diagnosis
Treatment/complications
Prospects of eradication/eradication strategies
Available vaccines
Research needs
References
Measles 50 Years After Use of Measles Vaccine
Key points
Introduction
Measles historical aspects and virology
Measles pathogenesis
Disease description
Prevaccine measles disease burden
Measles epidemiology
Prevention by vaccination
Patient history
Differential diagnosis
Diagnostic and laboratory testing
Therapeutic options and case management
Prospects of eradication and eradication strategies
Challenges and opportunities
References
Approach to Immunization for the Traveling Child
Key points
Introduction
Immunization practices
Routine immunizations of importance for travelers
Health preparation for long-stay travelers
Recommended travel immunizations
Travel vaccines not available in the United States
Future travel vaccines
References
Promoting Vaccine Confidence
Key points
Introduction
What is vaccine hesitancy anyway?
How common is vaccine hesitancy?
Complacency and vaccine risk perceptions
Confidence in vaccine safety
Confidence in the health care system
Addressing vaccine hesitancy
Delivering the message
Strategies for communicating with vaccine-hesitant parents
Prologue: back to Disney
References
Index
Copyright
Elsevier
1600 John F. Kennedy Boulevard Suite 1800 Philadelphia, Pennsylvania, 19103-2899.
http://www.theclinics.com
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA Volume 29, Number 4
December 2015 ISSN 0891-5520, ISBN-13: 978-0-323-40252-1
Editor: Kerry Holland
Developmental Editor: Donald Mumford
2015 Elsevier Inc. All rights reserved.
This periodical and the individual contributions contained in it are protected under copyright by Elsevier, and the following terms and conditions apply to their use:
Photocopying
Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the Publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. For information on how to seek permission visit www.elsevier.com/permissions or call: ([phone] (UK)/([phone] (USA).
Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations (please consult www.elsevier.com/permissions ).
Electronic Storage or Usage
Permission of the Publisher is required to store or use electronically any material contained in this periodical, including any article or part of an article (please consult www.elsevier.com/permissions ). Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher.
Notice
No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Infectious Disease Clinics of North America (ISSN 0891-5520) is published in March, June, September, and December by Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710. Periodicals postage paid at New York, NY and additional mailing offices. Subscription prices are $295.00 per year for US individuals, $510.00 per year for US institutions, $145.00 per year for US students, $350.00 per year for Canadian individuals, $638.00 per year for Canadian institutions, $420.00 per year for international individuals, $638.00 per year for international institutions, and $200.00 per year for Canadian and international students. To receive student rate, orders must be accompained by name of affiliated institution, date of term, and the signature of program/residency coordinator on institution letterhead. Orders will be billed at individual rate until proof of status is received. Foreign air speed delivery is included in all Clinics subscription prices. All prices are subject to change without notice. POSTMASTER : Send address changes to Infectious Disease Clinics of North America, Elsevier Health Sciences Division, Subcription Customer Service, 3251 Riverport Lane, Maryland Heights, MO 63043. Customer Service: 1-800-654-2452 (US). From outside of the US and Canada, call 1-314-447-8871. Fax: [phone]. E-mail: [e-mail] (print support) or [e-mail] (online support).
Infectious Disease Clinics of North America is also published in Spanish by Editorial Inter-M dica, Junin 917, 1 er A 1113, Buenos Aires, Argentina.
Reprints . For copies of 100 or more, of articles in this publication, please contact the Commercial Reprints Department, Elsevier Inc., 360 Park Avenue South, New York, New York 10010-1710. Tel. [phone], Fax: [phone], E-mail: [e-mail] .
Infectious Disease Clinics of North America is covered in MEDLINE/PubMed (Index Medicus), Current Contents/Clinical Medicine, Science Citation Alert, SCISEARCH, and Research Alert.
Printed in the United States of America.
Contributors
Consulting Editor
HELEN W. BOUCHER, MD, FIDSA, FACP , Director, Infectious Diseases Fellowship Program, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center; Associate Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts
Editors
MARY ANNE JACKSON, MD, FAAP, FPIDS, FIDSA , Division of Pediatric Infectious Diseases, Director of Pediatric Infectious Diseases and Associate Chair of Pediatrics, Children's Mercy Hospital; Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
ANGELA L. MYERS, MD, MPH, FAAP, FPIDS , Division of Pediatric Infectious Diseases, Director, Travel Medicine; Director, Pediatric Infectious Diseases Fellowship Training Program, Children's Mercy Hospitals and Clinics; Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Authors
KEVIN A. AULT, MD , Professor and Division Director, De